About us
+
Seqens group
Governance
Scientific committee
Compliance
Our Partners
Locations
R&D Services
+
Key expertise
Excellence centers
Sustainability
+
Vision & Strategy
Environment
Operation integrity
People and Communities
Safety, Quality and Sustainable Innovation
CSR Performance
CSR Library
Careers
+
Join the Seqens adventure
Our Commitment to Youth
Our jobs and our teams
Knowledge center
Activities
+
Pharmaceuticals
Personal care
Custom & Specialties
Cell&gene
Products
en
fr
Show menu
Les dernières actualités du Groupe SEQENS
All news
Events
General
In short
OPAS sur les titres de PCAS SA
Press release
Products & Technologies
Protéus
RSE
SD-CSR
07/04/2023
General
New investments in China
Read more
24/03/2023
General
Seqens group at DCAT Week 2023
Read more
31/01/2023
Seqens Group Opens Flagship Pharmaceutical R&D Center in Boston
Read more
16/01/2023
General
Seqens chooses to reshore Paracetamol production in France : work on the future plant has begun.
Read more
09/03/2022
General
Meeting with Virginie Tarlet for the International Women’s Day
Read more
08/03/2022
General
Meeting with Aïna Queiroz for the International Women’s Day
Read more
08/03/2022
General
Meeting with Yael Gofni for the International Women’s Day
Read more
25/01/2022
General
Update on isopropanol plant expansion
Read more
17/12/2021
SK Capital becomes the new majority shareholder of Seqens – Q&A
Read more
16/12/2021
General
Seqens becomes a partner of the RoLA-FLEX project
Read more
24/11/2021
General
Seqens Prize of the French Académie des Sciences 2021
Read more
06/10/2021
Raw materials, energy and transport: rising prices & availability
Read more
1
2
3
…
36
+
OPAS SUR LES TITRES DE PCAS SA
CLOSE
